Emergency Department Pediatric Readiness and Potentially Avoidable Transfers

Monica K Lieng1, James P Marcin1, Parul Dayal1

  • 1Department of Pediatrics, University of California, Davis Health, Sacramento, CA.

Insights

Higher pediatric readiness in emergency departments (EDs) is linked to fewer potentially avoidable transfers (PATs) for children. Improving specific readiness components can help reduce these transfers.

Area of Science:

  • Pediatric Emergency Medicine
  • Healthcare Quality Improvement
  • Health Services Research

Background:

  • Potentially avoidable transfers (PATs) represent suboptimal care coordination for pediatric patients.
  • Assessing emergency department (ED) pediatric readiness is crucial for evaluating care quality.

Purpose of the Study:

  • To investigate the association between pediatric readiness scores in EDs and the occurrence of PATs.
  • To identify specific components of ED pediatric readiness that may influence PAT rates.

Main Methods:

  • Cross-sectional study linking California ED/inpatient data (2011-2013) with the 2012 National Pediatric Readiness Project assessment.
  • Defined PATs based on discharge timing and absence of specialized procedures.
  • Used mixed-effects logistic regression to compare PATs with necessary transfers, adjusting for covariates.

Main Results:

  • A 10-point increase in pediatric readiness was associated with reduced odds of PATs for both injured and non-injured children.
  • Adjusted analyses confirmed this association for injured children but not for non-injured children.
  • Having a nurse pediatric emergency care coordinator and a quality improvement plan were linked to fewer PATs.

Conclusions:

  • Enhanced pediatric readiness in hospital EDs correlates with a lower likelihood of PATs.
  • Specific, modifiable pediatric readiness components offer targets for interventions aimed at reducing PATs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
59
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
75
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
53
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
51